Evangelia Vamvaka

Lleida, CT 25198, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon-like peptide-1 and glucagon receptor in healthy subjects.

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon-like peptide-1 and glucagon receptor in healthy subjects.

Journal: British journal of clinical pharmacology

Published: March 06, 2025

Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial.

Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial.

Journal: BMJ open

Published: October 07, 2022

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.

Journal: NEJM evidence

Published: January 01, 2022

Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study.

Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study.

Journal: BMJ open

Published: April 14, 2021

Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm.

Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 01, 2018

Cyanovirin-N produced in rice endosperm offers effective pre-exposure prophylaxis against HIV-1BaL infection in vitro.

Cyanovirin-N produced in rice endosperm offers effective pre-exposure prophylaxis against HIV-1BaL infection in vitro.

Journal: Plant cell reports

Published: November 14, 2015

Rice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV.

Rice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV.

Journal: Plant biotechnology journal

Published: April 21, 2015

Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12.

Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12.

Journal: Plant biotechnology journal

Published: November 12, 2014

Can plant biotechnology help break the HIV-malaria link?

Can plant biotechnology help break the HIV-malaria link?

Journal: Biotechnology advances

Published: January 13, 2014

Engineering metabolic pathways in plants by multigene transformation.

Engineering metabolic pathways in plants by multigene transformation.

Journal: The International journal of developmental biology

Published: October 30, 2013

Can the world afford to ignore biotechnology solutions that address food insecurity?

Can the world afford to ignore biotechnology solutions that address food insecurity?

Journal: Plant molecular biology

Published: December 18, 2012

The contribution of transgenic plants to better health through improved nutrition: opportunities and constraints.

The contribution of transgenic plants to better health through improved nutrition: opportunities and constraints.

Journal: Genes & nutrition

Published: February 11, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026